French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring…
28/05/2020 - 2 minutes
Cancer
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
15/05/2020 - 4 minutes
Oncopeptides’ Share Issue Bags €133M to Take Cancer Drug to Market
Swedish biotech Oncopeptides has raised €133M (SEK 1.4B) by issuing new company shares, surpassing expectations…
14/05/2020 - 3 minutes
Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland
The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop…
24/04/2020 - 3 minutes
€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
22/04/2020 - 3 minutes
Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer
Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs,…
17/04/2020 - 3 minutes
Coronavirus Pandemic Bites into European Cancer Research
The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced…
10/04/2020 - 4 minutes
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which…
02/04/2020 - 3 minutes
Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop…
31/03/2020 - 3 minutes
This Startup is Making a Cancer Vaccine out of Viruses
Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine…
27/03/2020 - 4 minutes
Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II
The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial…
24/03/2020 - 2 minutes
OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments
Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M…
18/03/2020 - 2 minutes
